135 results
Page 5 of 7
8-K
EX-99.1
ekmky2v
5 Nov 19
Avinger Reports Third Quarter 2019 Financial Results
4:05pm
424B5
sq03els
22 Aug 19
Prospectus supplement for primary offering
5:02pm
8-K
EX-1.1
n8ftj1gc8bv ei
22 Aug 19
Entry into a Material Definitive Agreement
8:45am
424B5
0uzhj3yu7 zkbls
21 Aug 19
Prospectus supplement for primary offering
4:36pm
8-K
EX-99.1
gimv7txfaye0 6pxpqq
31 Jul 19
Avinger Reports 26% Sequential Revenue Growth in Second Quarter 2019
4:06pm
8-K
EX-99.1
qa0z5f
21 Jun 19
Material Modifications to Rights of Security Holders
4:00pm
8-K
EX-99.1
yfijbmz 0l
8 May 19
Avinger Provides First Quarter 2019 Shareholder Update
4:05pm
8-K
EX-99.1
joafyig
10 Apr 19
Avinger Receives FDA Clearance of Pantheris SV Device
8:05am
POS AM
4tlkz9k nlzy3f
14 Mar 19
Prospectus update (post-effective amendment)
4:42pm
8-K
EX-99.1
sb3 fdzq5fykicvr
6 Mar 19
Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update
4:05pm
8-K
EX-99.1
kx05ti48pl9p259anuu
14 Nov 18
Avinger Provides Third Quarter 2018 Shareholder Update
12:00am